{"gene":"GUCA1B","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1997,"finding":"GCAP-2 is N-terminally fatty acylated (myristoylated), but unlike other recoverin-family members, myristoylation is not required for activation of RetGC or for Ca2+-loaded GCAP-2 to inhibit constitutively active GCAP-2 mutants; instead, Ca2+ binding is the primary regulatory switch controlling RetGC activity.","method":"In vitro RetGC activity assays using myristoylated vs. non-myristoylated (Gly2→Ala2 mutant) GCAP-2 expressed in E. coli and HEK293 cells; membrane fractionation at varying Ca2+ concentrations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis; replicated across expression systems","pmids":["9162068"],"is_preprint":false},{"year":1999,"finding":"Three functional domains in GCAP-2 are essential for RetGC regulation: (1) residues Phe78–Asp113 determine whether GCAP-2 activates RetGC at low or high Ca2+; (2) residues Lys29–Phe48 (including EF-hand 1) are essential for both activation at low Ca2+ and inhibition at high Ca2+; (3) region Val171–Asn189 (adjacent to EF-4) contributes to activation but not to Ca2+-loaded inhibition of RetGC.","method":"In vitro RetGC activity assays using deletion mutants and chimeric proteins (GCAP-2 domains swapped with neurocalcin or recoverin sequences) expressed in E. coli and HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with in vitro functional reconstitution across multiple mutants","pmids":["10196158"],"is_preprint":false},{"year":1998,"finding":"GCAP-2 undergoes Ca2+-dependent conformational changes detectable by far-UV CD spectroscopy and differential V8 protease sensitivity, but unlike recoverin, Ca2+ binding does not cause proteolytic cleavage of the myristoylated N-terminus nor dramatically alter the chemical environment of the N-terminus (by NMR), indicating a distinct structural mechanism of Ca2+ response compared to recoverin.","method":"Far-UV circular dichroism spectroscopy, V8 protease partial digestion, and NMR spectroscopy of Ca2+-bound vs. Ca2+-free GCAP-2","journal":"Protein science : a publication of the Protein Society","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biophysical methods (CD, NMR, proteolysis) in single study","pmids":["9865963"],"is_preprint":false},{"year":2004,"finding":"GCAP-2 is phosphorylated at Ser201 by cyclic nucleotide-dependent protein kinases (CNDPK) present in retinal extract and rapidly dephosphorylated by retinal protein phosphatase PP2C; Ca2+ binding strongly inhibits this phosphorylation. Phosphorylation or Ser201 substitutions (S201G or S201D) do not significantly affect GCAP-2 regulation of retGC in vitro, and Ca2+-dependent conformational changes expose/constrain regions around Glu62 (EF-hand 2), near EF-hand 3, and Glu136–Glu138.","method":"In vitro phosphorylation assays with retinal extract kinase/phosphatase; site-directed mutagenesis (S201G, S201D); partial Glu-C protease digestion of Ca2+-bound vs. Ca2+-free GCAP-2; reconstituted retGC activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and structural probing via proteolysis","pmids":["15448139"],"is_preprint":false},{"year":2008,"finding":"GCAP2 regulates retGC in mouse rods: knockout of GUCA1B reduces the maximal rate of cGMP synthesis at low Ca2+ by 2-fold and shifts the half-maximal rate to higher Ca2+ concentrations. Loss of GCAP2 slows flash response recovery, increases rod sensitivity, and causes saturation at lower light intensities, demonstrating that GCAP2 accelerates recovery and adjusts the rod operating range.","method":"GUCA1B knockout mice; in vitro retGC activity assays with retinal membranes; single-cell and population rod electrophysiology; GCAP2-antibody inhibition of retGC in wild-type retinas","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined biochemical and electrophysiological phenotypes; antibody blockade confirms specificity","pmids":["18723510"],"is_preprint":false},{"year":2007,"finding":"The N-terminal myristoyl chain of GCAP-2 inserts fully into phospholipid membranes with moderate mobility comparable to membrane acyl chains; however, its free energy contribution to membrane binding is only ~−0.5 kJ/mol, indicating that the main driving force for membrane localization is hydrophobic protein side-chain–lipid interactions rather than myristoylation itself, suggesting the myristoyl group may instead directly contact retinal guanylyl cyclases.","method":"2H solid-state NMR spectroscopy of deuterium-labeled myristoyl-GCAP-2 in DMPC and physiological lipid vesicles; biochemical membrane-binding assay","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — solid-state NMR with quantitative thermodynamic analysis and orthogonal biochemical assay","pmids":["17936244"],"is_preprint":false},{"year":2010,"finding":"GCAP2 is present at photoreceptor ribbon synapses and specifically interacts with the RIBEYE protein (major component of synaptic ribbons) via the flexible hinge-2 linker region of RIBEYE(B) domain binding to the C-terminus of GCAP2; this interaction is induced by NADH binding to RIBEYE and modulated by its substrate-binding subdomain. Virus-mediated overexpression of GCAP2 in photoreceptor synaptic terminals reduces the number of synaptic ribbons.","method":"Co-immunoprecipitation, GST pull-down, proximity ligation assay, confocal microscopy localization, adeno-associated virus-mediated overexpression with ribbon counting","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal interaction assays plus functional overexpression phenotype","pmids":["20463219"],"is_preprint":false},{"year":2013,"finding":"GCAP-2 forms a homodimer both in the presence and absence of Ca2+; in the Ca2+-free state GCAP-2 is more conformationally flexible (more cross-links detected); the Ca2+-bound homodimer adopts a defined topology mapped by cross-linking/MS and molecular docking.","method":"Chemical cross-linking with 15N-stable isotope labeling, high-resolution mass spectrometry, size-exclusion chromatography, analytical ultracentrifugation, molecular dynamics docking","journal":"Journal of the American Society for Mass Spectrometry","confidence":"High","confidence_rationale":"Tier 1 — structural analysis with multiple orthogonal biophysical methods and isotope labeling controls","pmids":["24026978"],"is_preprint":false},{"year":2014,"finding":"GCAP2 locked in its Ca2+-free conformation (all EF-hands inactivated) is phosphorylated at Ser201 in vivo, leading to phospho-dependent binding to the chaperone 14-3-3 and retention at the inner segment/proximal cell compartments causing rapid retinal degeneration—independent of unabated cGMP synthesis. Under physiological conditions, ~50% of GCAP2 is phosphorylated and retained at the inner segment; constant light exposure increases this retention.","method":"Transgenic mice expressing EF-hand-inactivated GCAP2; immunofluorescence subcellular localization; co-immunoprecipitation with 14-3-3; retinal degeneration histology; cGMP measurements","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model with Co-IP, subcellular localization, and quantitative biochemistry; multiple orthogonal approaches","pmids":["25058152"],"is_preprint":false},{"year":2018,"finding":"ROS-GC1 interacts with GCAP-2 primarily through contacts between the C-terminal lobe of GCAP-2 and a peptide encompassing parts of ROS-GC1's catalytic domain and C-terminal extension; the dissociation constant is in the low micromolar range, and these interactions are modulated by Ca2+.","method":"Chemical cross-linking/mass spectrometry of GCAP-2 with ROS-GC1 peptides; surface plasmon resonance; fluorescence binding measurements","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — multiple binding assays but using peptide fragments rather than full-length ROS-GC1","pmids":["30283299"],"is_preprint":false},{"year":2021,"finding":"Human GCAP2 (myristoylated) binds up to 3 Mg2+ with high affinity and forms a compact dimer that reversibly dissociates in the presence of Ca2+; non-myristoylated GCAP2 does not bind Mg2+ over physiological ranges and remains monomeric without Ca2+. Unlike bovine/murine GCAP2, human GCAP2 does not significantly activate retinal GC1 in a Ca2+-dependent fashion. The IRD-associated G157R variant adopts a molten-globule-like conformation with reduced cation affinity and forms aggregates via hydrophobic interactions.","method":"Isothermal titration calorimetry, analytical ultracentrifugation, in vitro retGC1 activity assay, circular dichroism, dynamic light scattering; comparison of myristoylated vs. non-myristoylated forms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple orthogonal biophysical methods and mutagenesis analog (disease variant characterization)","pmids":["33812995"],"is_preprint":false},{"year":1997,"finding":"The human GCAP1 and GCAP2 genes are arranged in a tail-to-tail array less than 5 kb apart at chromosome 6p21.1, with identical four-exon/three-intron structures, consistent with a gene duplication event; GCAP2 mRNA (~2.2 kb) is detectable only in the retina.","method":"PCR analysis of exon-specific primers on somatic hybrid panels; FISH; Northern blotting","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct genomic mapping with FISH and PCR; expression confirmed by Northern blot","pmids":["9119368"],"is_preprint":false},{"year":2002,"finding":"GCAP1 alone at near-normal levels is sufficient to support wild-type flash responses in rod photoreceptors in the absence of GCAP2, as demonstrated by single-cell electrophysiology in transgenic mice expressing only GCAP1 on a GCAP1/GCAP2 knockout background.","method":"Transgenic rescue mice (GCAP1 expressed under endogenous promoter on GCAP null background); paired flash ERG; single-cell rod recordings","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean genetic rescue with single-cell electrophysiology; replicated at population and single-cell level","pmids":["11927539"],"is_preprint":false},{"year":2012,"finding":"Time-resolved fluorescence spectroscopy revealed that Ca2+ binding to GCAP2 causes site-specific conformational changes: Ca2+ binding increases solvent exposure at position 111 and moves position 131 into a hydrophobic protein cleft, consistent with a piston-like movement of an α-helix between these positions. Both Ca2+ and myristoylation increase orientational flexibility at position 111.","method":"Time-resolved fluorescence lifetime and rotational anisotropy measurements with site-specifically labeled Alexa647-GCAP2; wobbling-in-a-cone model analysis","journal":"ACS chemical biology","confidence":"Medium","confidence_rationale":"Tier 1 biophysical — single lab with site-specific labeling and multiple positions probed","pmids":["22409623"],"is_preprint":false}],"current_model":"GCAP2 (GUCA1B) is a myristoylated, Ca2+-binding neuronal calcium sensor protein that activates retinal guanylyl cyclases (retGC1/retGC2) at low [Ca2+] (light-adapted state) and inhibits them at high [Ca2+] (dark-adapted state) via Ca2+-dependent conformational changes in its EF-hands; Ca2+ binding—not a calcium-myristoyl switch—is the primary regulatory mechanism; GCAP2 is phosphorylated at Ser201 by retinal CNDPKs and dephosphorylated by PP2C, and when locked Ca2+-free, phospho-Ser201 drives 14-3-3 binding and inner-segment retention causing retinal degeneration; beyond the outer segment, GCAP2 localizes to photoreceptor ribbon synapses where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing the primary regulatory switch: although GCAP2 is myristoylated like other recoverin-family members, myristoylation is dispensable for retGC activation and inhibition, demonstrating that Ca²⁺ binding itself—not a calcium-myristoyl switch—is the functional regulator of cyclase activity.","evidence":"In vitro retGC activity assays comparing myristoylated and Gly2→Ala2 non-myristoylated GCAP2 in E. coli and HEK293 expression systems","pmids":["9162068"],"confidence":"High","gaps":["Structural basis for how Ca²⁺ binding without myristoyl switching activates/inhibits retGC was unknown","Role of myristoylation in cyclase binding vs. membrane anchoring not yet resolved"]},{"year":1997,"claim":"Genomic organization revealed that GUCA1B and GUCA1A are arranged tail-to-tail within 5 kb at 6p21.1 with identical exon-intron structures, establishing their origin by gene duplication, and GCAP2 mRNA expression is retina-restricted.","evidence":"PCR on somatic hybrid panels, FISH mapping, and Northern blotting","pmids":["9119368"],"confidence":"Medium","gaps":["Cell-type specificity within retina (rod vs. cone expression) not resolved","Regulatory elements controlling retina-specific transcription not identified"]},{"year":1998,"claim":"Biophysical characterization demonstrated that GCAP2 undergoes Ca²⁺-dependent conformational changes distinct from recoverin's calcium-myristoyl switch, with Ca²⁺ altering secondary structure and protease accessibility without dramatically remodeling the N-terminal myristoyl environment.","evidence":"Far-UV CD, V8 protease partial digestion, and NMR spectroscopy of Ca²⁺-bound vs. Ca²⁺-free GCAP2","pmids":["9865963"],"confidence":"High","gaps":["Atomic-resolution structure of Ca²⁺-free vs. Ca²⁺-bound GCAP2 not determined","Which specific conformational changes are transduced to retGC remained unknown"]},{"year":1999,"claim":"Systematic domain mapping identified three functional regions of GCAP2: Phe78–Asp113 sets the Ca²⁺-dependence polarity; Lys29–Phe48 (EF-hand 1 region) is essential for both activation and inhibition; Val171–Asn189 (near EF-4) selectively supports activation, establishing a modular architecture for cyclase regulation.","evidence":"Deletion mutants and chimeric proteins (GCAP2/neurocalcin/recoverin swaps) tested in retGC activity assays","pmids":["10196158"],"confidence":"High","gaps":["Direct contacts between these GCAP2 domains and retGC not mapped","Whether domains function independently or cooperatively was unclear"]},{"year":2002,"claim":"Genetic rescue experiments showed GCAP1 alone fully supports normal rod flash responses, raising the question of what non-redundant function GCAP2 provides in phototransduction.","evidence":"Transgenic mice expressing GCAP1 on a GCAP1/GCAP2 double-knockout background; single-cell rod electrophysiology","pmids":["11927539"],"confidence":"High","gaps":["GCAP2-specific contribution to light adaptation and operating range not yet tested","Cone photoreceptor function not examined"]},{"year":2004,"claim":"Identification of Ser201 phosphorylation by retinal CNDPKs and rapid dephosphorylation by PP2C established a post-translational regulatory layer on GCAP2, although phosphorylation did not directly alter retGC regulation in vitro, pointing to a non-cyclase function for this modification.","evidence":"In vitro phosphorylation with retinal extract kinases/phosphatases, S201G/S201D mutagenesis, Glu-C protease mapping, and retGC activity assays","pmids":["15448139"],"confidence":"High","gaps":["In vivo significance of Ser201 phosphorylation remained to be established","Specific kinase identity not confirmed beyond CNDPK class"]},{"year":2007,"claim":"Solid-state NMR revealed that the myristoyl group inserts fully into membranes but contributes minimally to membrane binding free energy, suggesting its primary role is direct contact with retGC rather than membrane anchoring.","evidence":"²H solid-state NMR of deuterium-labeled myristoyl-GCAP2 in lipid vesicles with quantitative thermodynamic analysis","pmids":["17936244"],"confidence":"High","gaps":["Direct structural evidence for myristoyl-retGC contact not obtained","How protein surface hydrophobic residues drive membrane association not mapped"]},{"year":2008,"claim":"GUCA1B knockout mice revealed that GCAP2 contributes approximately half of maximal retGC activation at low Ca²⁺, accelerates flash response recovery, and extends the rod operating range to higher light intensities—defining its non-redundant physiological role.","evidence":"GUCA1B knockout mice; retinal membrane retGC assays; single-cell and population rod electrophysiology; antibody blockade controls","pmids":["18723510"],"confidence":"High","gaps":["Whether GCAP2 has distinct roles in dark vs. light adaptation kinetics not fully resolved","Contribution to cone physiology untested"]},{"year":2010,"claim":"Discovery of GCAP2 at photoreceptor ribbon synapses, where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number, established an unexpected function beyond outer-segment phototransduction.","evidence":"Co-immunoprecipitation, GST pull-down, proximity ligation assay, confocal microscopy, AAV-mediated overexpression with ribbon quantification","pmids":["20463219"],"confidence":"High","gaps":["Mechanism by which GCAP2 regulates ribbon number (assembly vs. disassembly) unknown","Whether Ca²⁺ sensing by GCAP2 modulates its synaptic function not tested","Physiological consequence for synaptic transmission not measured"]},{"year":2012,"claim":"Time-resolved fluorescence revealed site-specific Ca²⁺-induced conformational changes consistent with a piston-like helix movement between positions 111 and 131, providing the first dynamic structural model of the Ca²⁺ switch in GCAP2.","evidence":"Time-resolved fluorescence lifetime and rotational anisotropy of site-specifically Alexa647-labeled GCAP2","pmids":["22409623"],"confidence":"Medium","gaps":["Model based on two probe positions; full structural validation lacking","Whether this helix movement is directly transmitted to retGC unknown"]},{"year":2013,"claim":"Cross-linking/MS and biophysical studies established that GCAP2 forms a homodimer in both Ca²⁺-bound and Ca²⁺-free states, with the Ca²⁺-free form being more conformationally flexible—suggesting dimerization may be functionally relevant for cyclase regulation.","evidence":"Chemical cross-linking with ¹⁵N-isotope labeling, high-resolution MS, size-exclusion chromatography, analytical ultracentrifugation, molecular docking","pmids":["24026978"],"confidence":"High","gaps":["Whether GCAP2 dimerization is required for retGC activation in vivo not tested","Stoichiometry of GCAP2–retGC complex including dimer interface unknown"]},{"year":2014,"claim":"In vivo studies resolved the function of Ser201 phosphorylation: when GCAP2 is locked Ca²⁺-free, phospho-Ser201 drives 14-3-3 binding and inner-segment retention, causing retinal degeneration independent of uncontrolled cGMP synthesis—revealing a cytotoxic chaperone-mediated pathway.","evidence":"Transgenic mice expressing EF-hand-inactivated GCAP2; immunofluorescence, co-IP with 14-3-3, retinal degeneration histology, cGMP measurements","pmids":["25058152"],"confidence":"High","gaps":["Identity of the kinase phosphorylating Ser201 in vivo not confirmed","Mechanism of degeneration downstream of 14-3-3 binding not elucidated","Whether this pathway operates in human disease mutations unknown"]},{"year":2018,"claim":"Mapping the GCAP2–retGC1 binding interface showed that the C-terminal lobe of GCAP2 contacts the catalytic domain and C-terminal extension of retGC1 with low-micromolar affinity, modulated by Ca²⁺.","evidence":"Chemical cross-linking/MS with retGC1 peptides, surface plasmon resonance, fluorescence binding measurements","pmids":["30283299"],"confidence":"Medium","gaps":["Peptide fragments rather than full-length retGC1 were used, so interface may be incomplete","Whether N-terminal myristoyl group contacts retGC1 directly was not resolved"]},{"year":2021,"claim":"Species-specific differences were uncovered: human myristoylated GCAP2 binds up to 3 Mg²⁺ and forms a compact dimer that dissociates upon Ca²⁺ binding, yet does not significantly activate retGC1 in vitro; the IRD-associated G157R variant adopts a molten-globule conformation with reduced cation affinity and aggregates.","evidence":"ITC, analytical ultracentrifugation, retGC1 activity assay, CD, and dynamic light scattering comparing myristoylated vs. non-myristoylated and wild-type vs. G157R human GCAP2","pmids":["33812995"],"confidence":"High","gaps":["Why human GCAP2 fails to activate retGC1 in vitro despite bovine/murine orthologs doing so is unexplained","Whether Mg²⁺-dependent dimerization is physiologically relevant in human rods unknown","Full structural characterization of G157R aggregates lacking"]},{"year":null,"claim":"Key unresolved questions include: the atomic-resolution structure of the GCAP2–retGC complex, the mechanism by which GCAP2 regulates synaptic ribbon assembly, whether the 14-3-3-mediated retention pathway operates in human inherited retinal disease, and why human GCAP2 does not activate retGC1 in vitro.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution GCAP2–retGC co-structure","Synaptic ribbon regulation mechanism uncharacterized","Human-specific retGC activation deficit unexplained","In vivo kinase identity for Ser201 phosphorylation unconfirmed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[0,2,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[4,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[6]}],"complexes":[],"partners":["GUCY2D","GUCY2F","RIBEYE","YWHAZ","GUCA1A"],"other_free_text":[]},"mechanistic_narrative":"GCAP2 (GUCA1B) is a myristoylated, EF-hand calcium sensor protein that regulates retinal guanylyl cyclases (retGC) to control cGMP synthesis during phototransduction, and additionally functions at photoreceptor ribbon synapses. At low Ca²⁺ concentrations (light-adapted state), GCAP2 activates retGC through Ca²⁺-sensitive conformational changes governed by specific EF-hand-containing domains, while at high Ca²⁺ (dark-adapted state) it inhibits cyclase activity; Ca²⁺ binding—not a calcium-myristoyl switch—serves as the primary regulatory mechanism, with myristoylation instead contributing to direct cyclase contacts [PMID:9162068, PMID:10196158, PMID:17936244]. In vivo, GCAP2 accelerates flash response recovery and extends the rod operating range, though GCAP1 alone can support normal rod responses [PMID:18723510, PMID:11927539]. GCAP2 is phosphorylated at Ser201 by cyclic nucleotide-dependent protein kinases and dephosphorylated by PP2C; when locked in a Ca²⁺-free conformation, phospho-Ser201 drives 14-3-3 binding and inner-segment retention, causing retinal degeneration independent of uncontrolled cGMP synthesis [PMID:15448139, PMID:25058152]. Beyond the outer segment, GCAP2 localizes to photoreceptor ribbon synapses where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number [PMID:20463219]."},"prefetch_data":{"uniprot":{"accession":"Q9UMX6","full_name":"Guanylyl cyclase-activating protein 2","aliases":["Guanylate cyclase activator 1B"],"length_aa":200,"mass_kda":23.4,"function":"Stimulates two retinal guanylyl cyclases (GCs) GUCY2D and GUCY2F when free calcium ions concentration is low, and inhibits GUCY2D and GUCY2F when free calcium ions concentration is elevated (By similarity). This Ca(2+)-sensitive regulation of GCs is a key event in recovery of the dark state of rod photoreceptors following light exposure (By similarity). May be involved in cone photoreceptor response and recovery of response in bright light (By similarity)","subcellular_location":"Cell membrane; Photoreceptor inner segment; Cell projection, cilium, photoreceptor outer segment","url":"https://www.uniprot.org/uniprotkb/Q9UMX6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GUCA1B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GUCA1B","total_profiled":1310},"omim":[{"mim_id":"613827","title":"RETINITIS PIGMENTOSA 48; RP48","url":"https://www.omim.org/entry/613827"},{"mim_id":"605128","title":"GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C","url":"https://www.omim.org/entry/605128"},{"mim_id":"602275","title":"GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B","url":"https://www.omim.org/entry/602275"},{"mim_id":"601271","title":"GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B","url":"https://www.omim.org/entry/601271"},{"mim_id":"600364","title":"GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A","url":"https://www.omim.org/entry/600364"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Microtubules","reliability":"Approved"},{"location":"Primary cilium","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Nuclear membrane","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":432.4}],"url":"https://www.proteinatlas.org/search/GUCA1B"},"hgnc":{"alias_symbol":["GCAP2","RP48","GCAP-2","GCAP-II"],"prev_symbol":[]},"alphafold":{"accession":"Q9UMX6","domains":[{"cath_id":"1.10.238.10","chopping":"17-132_139-196","consensus_level":"medium","plddt":74.684,"start":17,"end":196}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMX6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMX6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMX6-F1-predicted_aligned_error_v6.png","plddt_mean":71.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GUCA1B","jax_strain_url":"https://www.jax.org/strain/search?query=GUCA1B"},"sequence":{"accession":"Q9UMX6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UMX6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UMX6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMX6"}},"corpus_meta":[{"pmid":"9162068","id":"PMC_9162068","title":"Calcium binding, but not a calcium-myristoyl switch, controls the ability of guanylyl cyclase-activating protein GCAP-2 to regulate photoreceptor guanylyl cyclase.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9162068","citation_count":120,"is_preprint":false},{"pmid":"11927539","id":"PMC_11927539","title":"GCAP1 rescues rod photoreceptor response in GCAP1/GCAP2 knockout mice.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11927539","citation_count":93,"is_preprint":false},{"pmid":"18723510","id":"PMC_18723510","title":"A role for GCAP2 in regulating the photoresponse. Guanylyl cyclase activation and rod electrophysiology in GUCA1B knock-out mice.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18723510","citation_count":75,"is_preprint":false},{"pmid":"7589507","id":"PMC_7589507","title":"GCAP-II: isolation and characterization of the circulating form of human uroguanylin.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7589507","citation_count":61,"is_preprint":false},{"pmid":"12732716","id":"PMC_12732716","title":"Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAP1/GCAP2 knockout mice.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12732716","citation_count":59,"is_preprint":false},{"pmid":"15452722","id":"PMC_15452722","title":"Mutations in the gene coding for guanylate cyclase-activating protein 2 (GUCA1B gene) in patients with autosomal dominant retinal dystrophies.","date":"2004","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/15452722","citation_count":47,"is_preprint":false},{"pmid":"10196158","id":"PMC_10196158","title":"Mapping functional domains of the guanylate cyclase regulator protein, GCAP-2.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10196158","citation_count":44,"is_preprint":false},{"pmid":"8519795","id":"PMC_8519795","title":"A new human guanylate cyclase-activating peptide (GCAP-II, uroguanylin): precursor cDNA and colonic expression.","date":"1995","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8519795","citation_count":42,"is_preprint":false},{"pmid":"9119368","id":"PMC_9119368","title":"The human GCAP1 and GCAP2 genes are arranged in a tail-to-tail array on the short arm of chromosome 6 (p21.1).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9119368","citation_count":39,"is_preprint":false},{"pmid":"9865963","id":"PMC_9865963","title":"Ca2+-dependent conformational changes in bovine GCAP-2.","date":"1998","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/9865963","citation_count":38,"is_preprint":false},{"pmid":"8641465","id":"PMC_8641465","title":"Expression of GCAP1 and GCAP2 in the retinal degeneration (rd) mutant chicken retina.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8641465","citation_count":31,"is_preprint":false},{"pmid":"10507726","id":"PMC_10507726","title":"Genetic analysis of the guanylate cyclase activator 1B (GUCA1B) gene in patients with autosomal dominant retinal dystrophies.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10507726","citation_count":30,"is_preprint":false},{"pmid":"24026978","id":"PMC_24026978","title":"Structural analysis of guanylyl cyclase-activating protein-2 (GCAP-2) homodimer by stable isotope-labeling, chemical cross-linking, and mass spectrometry.","date":"2013","source":"Journal of the American Society for Mass Spectrometry","url":"https://pubmed.ncbi.nlm.nih.gov/24026978","citation_count":26,"is_preprint":false},{"pmid":"20463219","id":"PMC_20463219","title":"Nicotinamide adenine dinucleotide-dependent binding of the neuronal Ca2+ sensor protein GCAP2 to photoreceptor synaptic ribbons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20463219","citation_count":25,"is_preprint":false},{"pmid":"17936244","id":"PMC_17936244","title":"Characterization of the myristoyl lipid modification of membrane-bound GCAP-2 by 2H solid-state NMR spectroscopy.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17936244","citation_count":24,"is_preprint":false},{"pmid":"9344659","id":"PMC_9344659","title":"The uroguanylin gene (Guca1b) is linked to guanylin (Guca2) on mouse chromosome 4.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9344659","citation_count":18,"is_preprint":false},{"pmid":"15448139","id":"PMC_15448139","title":"Ca(2+)-dependent conformational changes in guanylyl cyclase-activating protein 2 (GCAP-2) revealed by site-specific phosphorylation and partial proteolysis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15448139","citation_count":16,"is_preprint":false},{"pmid":"21405999","id":"PMC_21405999","title":"Mutation screening of the GUCA1B gene in patients with autosomal dominant cone and cone rod dystrophy.","date":"2011","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21405999","citation_count":14,"is_preprint":false},{"pmid":"25058152","id":"PMC_25058152","title":"Functional EF-hands in neuronal calcium sensor GCAP2 determine its phosphorylation state and subcellular distribution in vivo, and are essential for photoreceptor cell integrity.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25058152","citation_count":12,"is_preprint":false},{"pmid":"33812995","id":"PMC_33812995","title":"Molecular properties of human guanylate cyclase-activating protein 2 (GCAP2) and its retinal dystrophy-associated variant G157R.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33812995","citation_count":10,"is_preprint":false},{"pmid":"22409623","id":"PMC_22409623","title":"Probing the Ca(2+) switch of the neuronal Ca(2+) sensor GCAP2 by time-resolved fluorescence spectroscopy.","date":"2012","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/22409623","citation_count":9,"is_preprint":false},{"pmid":"30283299","id":"PMC_30283299","title":"Molecular Details of Retinal Guanylyl Cyclase 1/GCAP-2 Interaction.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30283299","citation_count":8,"is_preprint":false},{"pmid":"27104297","id":"PMC_27104297","title":"Mapping Calcium-Sensitive Regions in the Neuronal Calcium Sensor GCAP2 by Site-Specific Fluorescence Labeling.","date":"2016","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27104297","citation_count":8,"is_preprint":false},{"pmid":"15901556","id":"PMC_15901556","title":"[Analysis of GUCA1B,GNGT1 and RGS9 genes in patients with retinitis pigmentosa].","date":"2002","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/15901556","citation_count":3,"is_preprint":false},{"pmid":"12151097","id":"PMC_12151097","title":"Characterisation of two genes for guanylate cyclase activator protein (GCAP1 and GCAP2) in the Japanese pufferfish, Fugu rubripes.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12151097","citation_count":1,"is_preprint":false},{"pmid":"41189896","id":"PMC_41189896","title":"Case Report: novel GUCA1B and ABHD12 mutations in retinitis pigmentosa sine pigmento: expanding the genotypic spectrum through multimodal phenotyping.","date":"2025","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41189896","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14098,"output_tokens":3900,"usd":0.050397},"stage2":{"model":"claude-opus-4-6","input_tokens":7313,"output_tokens":3755,"usd":0.19566},"total_usd":0.246057,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"GCAP-2 is N-terminally fatty acylated (myristoylated), but unlike other recoverin-family members, myristoylation is not required for activation of RetGC or for Ca2+-loaded GCAP-2 to inhibit constitutively active GCAP-2 mutants; instead, Ca2+ binding is the primary regulatory switch controlling RetGC activity.\",\n      \"method\": \"In vitro RetGC activity assays using myristoylated vs. non-myristoylated (Gly2→Ala2 mutant) GCAP-2 expressed in E. coli and HEK293 cells; membrane fractionation at varying Ca2+ concentrations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis; replicated across expression systems\",\n      \"pmids\": [\"9162068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Three functional domains in GCAP-2 are essential for RetGC regulation: (1) residues Phe78–Asp113 determine whether GCAP-2 activates RetGC at low or high Ca2+; (2) residues Lys29–Phe48 (including EF-hand 1) are essential for both activation at low Ca2+ and inhibition at high Ca2+; (3) region Val171–Asn189 (adjacent to EF-4) contributes to activation but not to Ca2+-loaded inhibition of RetGC.\",\n      \"method\": \"In vitro RetGC activity assays using deletion mutants and chimeric proteins (GCAP-2 domains swapped with neurocalcin or recoverin sequences) expressed in E. coli and HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with in vitro functional reconstitution across multiple mutants\",\n      \"pmids\": [\"10196158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GCAP-2 undergoes Ca2+-dependent conformational changes detectable by far-UV CD spectroscopy and differential V8 protease sensitivity, but unlike recoverin, Ca2+ binding does not cause proteolytic cleavage of the myristoylated N-terminus nor dramatically alter the chemical environment of the N-terminus (by NMR), indicating a distinct structural mechanism of Ca2+ response compared to recoverin.\",\n      \"method\": \"Far-UV circular dichroism spectroscopy, V8 protease partial digestion, and NMR spectroscopy of Ca2+-bound vs. Ca2+-free GCAP-2\",\n      \"journal\": \"Protein science : a publication of the Protein Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical methods (CD, NMR, proteolysis) in single study\",\n      \"pmids\": [\"9865963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GCAP-2 is phosphorylated at Ser201 by cyclic nucleotide-dependent protein kinases (CNDPK) present in retinal extract and rapidly dephosphorylated by retinal protein phosphatase PP2C; Ca2+ binding strongly inhibits this phosphorylation. Phosphorylation or Ser201 substitutions (S201G or S201D) do not significantly affect GCAP-2 regulation of retGC in vitro, and Ca2+-dependent conformational changes expose/constrain regions around Glu62 (EF-hand 2), near EF-hand 3, and Glu136–Glu138.\",\n      \"method\": \"In vitro phosphorylation assays with retinal extract kinase/phosphatase; site-directed mutagenesis (S201G, S201D); partial Glu-C protease digestion of Ca2+-bound vs. Ca2+-free GCAP-2; reconstituted retGC activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and structural probing via proteolysis\",\n      \"pmids\": [\"15448139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GCAP2 regulates retGC in mouse rods: knockout of GUCA1B reduces the maximal rate of cGMP synthesis at low Ca2+ by 2-fold and shifts the half-maximal rate to higher Ca2+ concentrations. Loss of GCAP2 slows flash response recovery, increases rod sensitivity, and causes saturation at lower light intensities, demonstrating that GCAP2 accelerates recovery and adjusts the rod operating range.\",\n      \"method\": \"GUCA1B knockout mice; in vitro retGC activity assays with retinal membranes; single-cell and population rod electrophysiology; GCAP2-antibody inhibition of retGC in wild-type retinas\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined biochemical and electrophysiological phenotypes; antibody blockade confirms specificity\",\n      \"pmids\": [\"18723510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The N-terminal myristoyl chain of GCAP-2 inserts fully into phospholipid membranes with moderate mobility comparable to membrane acyl chains; however, its free energy contribution to membrane binding is only ~−0.5 kJ/mol, indicating that the main driving force for membrane localization is hydrophobic protein side-chain–lipid interactions rather than myristoylation itself, suggesting the myristoyl group may instead directly contact retinal guanylyl cyclases.\",\n      \"method\": \"2H solid-state NMR spectroscopy of deuterium-labeled myristoyl-GCAP-2 in DMPC and physiological lipid vesicles; biochemical membrane-binding assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — solid-state NMR with quantitative thermodynamic analysis and orthogonal biochemical assay\",\n      \"pmids\": [\"17936244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GCAP2 is present at photoreceptor ribbon synapses and specifically interacts with the RIBEYE protein (major component of synaptic ribbons) via the flexible hinge-2 linker region of RIBEYE(B) domain binding to the C-terminus of GCAP2; this interaction is induced by NADH binding to RIBEYE and modulated by its substrate-binding subdomain. Virus-mediated overexpression of GCAP2 in photoreceptor synaptic terminals reduces the number of synaptic ribbons.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, proximity ligation assay, confocal microscopy localization, adeno-associated virus-mediated overexpression with ribbon counting\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal interaction assays plus functional overexpression phenotype\",\n      \"pmids\": [\"20463219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GCAP-2 forms a homodimer both in the presence and absence of Ca2+; in the Ca2+-free state GCAP-2 is more conformationally flexible (more cross-links detected); the Ca2+-bound homodimer adopts a defined topology mapped by cross-linking/MS and molecular docking.\",\n      \"method\": \"Chemical cross-linking with 15N-stable isotope labeling, high-resolution mass spectrometry, size-exclusion chromatography, analytical ultracentrifugation, molecular dynamics docking\",\n      \"journal\": \"Journal of the American Society for Mass Spectrometry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural analysis with multiple orthogonal biophysical methods and isotope labeling controls\",\n      \"pmids\": [\"24026978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GCAP2 locked in its Ca2+-free conformation (all EF-hands inactivated) is phosphorylated at Ser201 in vivo, leading to phospho-dependent binding to the chaperone 14-3-3 and retention at the inner segment/proximal cell compartments causing rapid retinal degeneration—independent of unabated cGMP synthesis. Under physiological conditions, ~50% of GCAP2 is phosphorylated and retained at the inner segment; constant light exposure increases this retention.\",\n      \"method\": \"Transgenic mice expressing EF-hand-inactivated GCAP2; immunofluorescence subcellular localization; co-immunoprecipitation with 14-3-3; retinal degeneration histology; cGMP measurements\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with Co-IP, subcellular localization, and quantitative biochemistry; multiple orthogonal approaches\",\n      \"pmids\": [\"25058152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ROS-GC1 interacts with GCAP-2 primarily through contacts between the C-terminal lobe of GCAP-2 and a peptide encompassing parts of ROS-GC1's catalytic domain and C-terminal extension; the dissociation constant is in the low micromolar range, and these interactions are modulated by Ca2+.\",\n      \"method\": \"Chemical cross-linking/mass spectrometry of GCAP-2 with ROS-GC1 peptides; surface plasmon resonance; fluorescence binding measurements\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple binding assays but using peptide fragments rather than full-length ROS-GC1\",\n      \"pmids\": [\"30283299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human GCAP2 (myristoylated) binds up to 3 Mg2+ with high affinity and forms a compact dimer that reversibly dissociates in the presence of Ca2+; non-myristoylated GCAP2 does not bind Mg2+ over physiological ranges and remains monomeric without Ca2+. Unlike bovine/murine GCAP2, human GCAP2 does not significantly activate retinal GC1 in a Ca2+-dependent fashion. The IRD-associated G157R variant adopts a molten-globule-like conformation with reduced cation affinity and forms aggregates via hydrophobic interactions.\",\n      \"method\": \"Isothermal titration calorimetry, analytical ultracentrifugation, in vitro retGC1 activity assay, circular dichroism, dynamic light scattering; comparison of myristoylated vs. non-myristoylated forms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple orthogonal biophysical methods and mutagenesis analog (disease variant characterization)\",\n      \"pmids\": [\"33812995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The human GCAP1 and GCAP2 genes are arranged in a tail-to-tail array less than 5 kb apart at chromosome 6p21.1, with identical four-exon/three-intron structures, consistent with a gene duplication event; GCAP2 mRNA (~2.2 kb) is detectable only in the retina.\",\n      \"method\": \"PCR analysis of exon-specific primers on somatic hybrid panels; FISH; Northern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic mapping with FISH and PCR; expression confirmed by Northern blot\",\n      \"pmids\": [\"9119368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GCAP1 alone at near-normal levels is sufficient to support wild-type flash responses in rod photoreceptors in the absence of GCAP2, as demonstrated by single-cell electrophysiology in transgenic mice expressing only GCAP1 on a GCAP1/GCAP2 knockout background.\",\n      \"method\": \"Transgenic rescue mice (GCAP1 expressed under endogenous promoter on GCAP null background); paired flash ERG; single-cell rod recordings\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic rescue with single-cell electrophysiology; replicated at population and single-cell level\",\n      \"pmids\": [\"11927539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Time-resolved fluorescence spectroscopy revealed that Ca2+ binding to GCAP2 causes site-specific conformational changes: Ca2+ binding increases solvent exposure at position 111 and moves position 131 into a hydrophobic protein cleft, consistent with a piston-like movement of an α-helix between these positions. Both Ca2+ and myristoylation increase orientational flexibility at position 111.\",\n      \"method\": \"Time-resolved fluorescence lifetime and rotational anisotropy measurements with site-specifically labeled Alexa647-GCAP2; wobbling-in-a-cone model analysis\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 biophysical — single lab with site-specific labeling and multiple positions probed\",\n      \"pmids\": [\"22409623\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GCAP2 (GUCA1B) is a myristoylated, Ca2+-binding neuronal calcium sensor protein that activates retinal guanylyl cyclases (retGC1/retGC2) at low [Ca2+] (light-adapted state) and inhibits them at high [Ca2+] (dark-adapted state) via Ca2+-dependent conformational changes in its EF-hands; Ca2+ binding—not a calcium-myristoyl switch—is the primary regulatory mechanism; GCAP2 is phosphorylated at Ser201 by retinal CNDPKs and dephosphorylated by PP2C, and when locked Ca2+-free, phospho-Ser201 drives 14-3-3 binding and inner-segment retention causing retinal degeneration; beyond the outer segment, GCAP2 localizes to photoreceptor ribbon synapses where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GCAP2 (GUCA1B) is a myristoylated, EF-hand calcium sensor protein that regulates retinal guanylyl cyclases (retGC) to control cGMP synthesis during phototransduction, and additionally functions at photoreceptor ribbon synapses. At low Ca²⁺ concentrations (light-adapted state), GCAP2 activates retGC through Ca²⁺-sensitive conformational changes governed by specific EF-hand-containing domains, while at high Ca²⁺ (dark-adapted state) it inhibits cyclase activity; Ca²⁺ binding—not a calcium-myristoyl switch—serves as the primary regulatory mechanism, with myristoylation instead contributing to direct cyclase contacts [PMID:9162068, PMID:10196158, PMID:17936244]. In vivo, GCAP2 accelerates flash response recovery and extends the rod operating range, though GCAP1 alone can support normal rod responses [PMID:18723510, PMID:11927539]. GCAP2 is phosphorylated at Ser201 by cyclic nucleotide-dependent protein kinases and dephosphorylated by PP2C; when locked in a Ca²⁺-free conformation, phospho-Ser201 drives 14-3-3 binding and inner-segment retention, causing retinal degeneration independent of uncontrolled cGMP synthesis [PMID:15448139, PMID:25058152]. Beyond the outer segment, GCAP2 localizes to photoreceptor ribbon synapses where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number [PMID:20463219].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing the primary regulatory switch: although GCAP2 is myristoylated like other recoverin-family members, myristoylation is dispensable for retGC activation and inhibition, demonstrating that Ca²⁺ binding itself—not a calcium-myristoyl switch—is the functional regulator of cyclase activity.\",\n      \"evidence\": \"In vitro retGC activity assays comparing myristoylated and Gly2→Ala2 non-myristoylated GCAP2 in E. coli and HEK293 expression systems\",\n      \"pmids\": [\"9162068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how Ca²⁺ binding without myristoyl switching activates/inhibits retGC was unknown\", \"Role of myristoylation in cyclase binding vs. membrane anchoring not yet resolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Genomic organization revealed that GUCA1B and GUCA1A are arranged tail-to-tail within 5 kb at 6p21.1 with identical exon-intron structures, establishing their origin by gene duplication, and GCAP2 mRNA expression is retina-restricted.\",\n      \"evidence\": \"PCR on somatic hybrid panels, FISH mapping, and Northern blotting\",\n      \"pmids\": [\"9119368\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type specificity within retina (rod vs. cone expression) not resolved\", \"Regulatory elements controlling retina-specific transcription not identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Biophysical characterization demonstrated that GCAP2 undergoes Ca²⁺-dependent conformational changes distinct from recoverin's calcium-myristoyl switch, with Ca²⁺ altering secondary structure and protease accessibility without dramatically remodeling the N-terminal myristoyl environment.\",\n      \"evidence\": \"Far-UV CD, V8 protease partial digestion, and NMR spectroscopy of Ca²⁺-bound vs. Ca²⁺-free GCAP2\",\n      \"pmids\": [\"9865963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of Ca²⁺-free vs. Ca²⁺-bound GCAP2 not determined\", \"Which specific conformational changes are transduced to retGC remained unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Systematic domain mapping identified three functional regions of GCAP2: Phe78–Asp113 sets the Ca²⁺-dependence polarity; Lys29–Phe48 (EF-hand 1 region) is essential for both activation and inhibition; Val171–Asn189 (near EF-4) selectively supports activation, establishing a modular architecture for cyclase regulation.\",\n      \"evidence\": \"Deletion mutants and chimeric proteins (GCAP2/neurocalcin/recoverin swaps) tested in retGC activity assays\",\n      \"pmids\": [\"10196158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contacts between these GCAP2 domains and retGC not mapped\", \"Whether domains function independently or cooperatively was unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic rescue experiments showed GCAP1 alone fully supports normal rod flash responses, raising the question of what non-redundant function GCAP2 provides in phototransduction.\",\n      \"evidence\": \"Transgenic mice expressing GCAP1 on a GCAP1/GCAP2 double-knockout background; single-cell rod electrophysiology\",\n      \"pmids\": [\"11927539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GCAP2-specific contribution to light adaptation and operating range not yet tested\", \"Cone photoreceptor function not examined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of Ser201 phosphorylation by retinal CNDPKs and rapid dephosphorylation by PP2C established a post-translational regulatory layer on GCAP2, although phosphorylation did not directly alter retGC regulation in vitro, pointing to a non-cyclase function for this modification.\",\n      \"evidence\": \"In vitro phosphorylation with retinal extract kinases/phosphatases, S201G/S201D mutagenesis, Glu-C protease mapping, and retGC activity assays\",\n      \"pmids\": [\"15448139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of Ser201 phosphorylation remained to be established\", \"Specific kinase identity not confirmed beyond CNDPK class\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Solid-state NMR revealed that the myristoyl group inserts fully into membranes but contributes minimally to membrane binding free energy, suggesting its primary role is direct contact with retGC rather than membrane anchoring.\",\n      \"evidence\": \"²H solid-state NMR of deuterium-labeled myristoyl-GCAP2 in lipid vesicles with quantitative thermodynamic analysis\",\n      \"pmids\": [\"17936244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural evidence for myristoyl-retGC contact not obtained\", \"How protein surface hydrophobic residues drive membrane association not mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"GUCA1B knockout mice revealed that GCAP2 contributes approximately half of maximal retGC activation at low Ca²⁺, accelerates flash response recovery, and extends the rod operating range to higher light intensities—defining its non-redundant physiological role.\",\n      \"evidence\": \"GUCA1B knockout mice; retinal membrane retGC assays; single-cell and population rod electrophysiology; antibody blockade controls\",\n      \"pmids\": [\"18723510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GCAP2 has distinct roles in dark vs. light adaptation kinetics not fully resolved\", \"Contribution to cone physiology untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery of GCAP2 at photoreceptor ribbon synapses, where it binds RIBEYE in an NADH-dependent manner and regulates synaptic ribbon number, established an unexpected function beyond outer-segment phototransduction.\",\n      \"evidence\": \"Co-immunoprecipitation, GST pull-down, proximity ligation assay, confocal microscopy, AAV-mediated overexpression with ribbon quantification\",\n      \"pmids\": [\"20463219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which GCAP2 regulates ribbon number (assembly vs. disassembly) unknown\", \"Whether Ca²⁺ sensing by GCAP2 modulates its synaptic function not tested\", \"Physiological consequence for synaptic transmission not measured\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Time-resolved fluorescence revealed site-specific Ca²⁺-induced conformational changes consistent with a piston-like helix movement between positions 111 and 131, providing the first dynamic structural model of the Ca²⁺ switch in GCAP2.\",\n      \"evidence\": \"Time-resolved fluorescence lifetime and rotational anisotropy of site-specifically Alexa647-labeled GCAP2\",\n      \"pmids\": [\"22409623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Model based on two probe positions; full structural validation lacking\", \"Whether this helix movement is directly transmitted to retGC unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Cross-linking/MS and biophysical studies established that GCAP2 forms a homodimer in both Ca²⁺-bound and Ca²⁺-free states, with the Ca²⁺-free form being more conformationally flexible—suggesting dimerization may be functionally relevant for cyclase regulation.\",\n      \"evidence\": \"Chemical cross-linking with ¹⁵N-isotope labeling, high-resolution MS, size-exclusion chromatography, analytical ultracentrifugation, molecular docking\",\n      \"pmids\": [\"24026978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GCAP2 dimerization is required for retGC activation in vivo not tested\", \"Stoichiometry of GCAP2–retGC complex including dimer interface unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"In vivo studies resolved the function of Ser201 phosphorylation: when GCAP2 is locked Ca²⁺-free, phospho-Ser201 drives 14-3-3 binding and inner-segment retention, causing retinal degeneration independent of uncontrolled cGMP synthesis—revealing a cytotoxic chaperone-mediated pathway.\",\n      \"evidence\": \"Transgenic mice expressing EF-hand-inactivated GCAP2; immunofluorescence, co-IP with 14-3-3, retinal degeneration histology, cGMP measurements\",\n      \"pmids\": [\"25058152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase phosphorylating Ser201 in vivo not confirmed\", \"Mechanism of degeneration downstream of 14-3-3 binding not elucidated\", \"Whether this pathway operates in human disease mutations unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mapping the GCAP2–retGC1 binding interface showed that the C-terminal lobe of GCAP2 contacts the catalytic domain and C-terminal extension of retGC1 with low-micromolar affinity, modulated by Ca²⁺.\",\n      \"evidence\": \"Chemical cross-linking/MS with retGC1 peptides, surface plasmon resonance, fluorescence binding measurements\",\n      \"pmids\": [\"30283299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peptide fragments rather than full-length retGC1 were used, so interface may be incomplete\", \"Whether N-terminal myristoyl group contacts retGC1 directly was not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Species-specific differences were uncovered: human myristoylated GCAP2 binds up to 3 Mg²⁺ and forms a compact dimer that dissociates upon Ca²⁺ binding, yet does not significantly activate retGC1 in vitro; the IRD-associated G157R variant adopts a molten-globule conformation with reduced cation affinity and aggregates.\",\n      \"evidence\": \"ITC, analytical ultracentrifugation, retGC1 activity assay, CD, and dynamic light scattering comparing myristoylated vs. non-myristoylated and wild-type vs. G157R human GCAP2\",\n      \"pmids\": [\"33812995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why human GCAP2 fails to activate retGC1 in vitro despite bovine/murine orthologs doing so is unexplained\", \"Whether Mg²⁺-dependent dimerization is physiologically relevant in human rods unknown\", \"Full structural characterization of G157R aggregates lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the atomic-resolution structure of the GCAP2–retGC complex, the mechanism by which GCAP2 regulates synaptic ribbon assembly, whether the 14-3-3-mediated retention pathway operates in human inherited retinal disease, and why human GCAP2 does not activate retGC1 in vitro.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution GCAP2–retGC co-structure\", \"Synaptic ribbon regulation mechanism uncharacterized\", \"Human-specific retGC activation deficit unexplained\", \"In vivo kinase identity for Ser201 phosphorylation unconfirmed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [4, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GUCY2D\",\n      \"GUCY2F\",\n      \"RIBEYE\",\n      \"YWHAZ\",\n      \"GUCA1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}